在医院协议修订后,限制万科米辛加载剂量对患有甲素耐药黄金葡萄球菌感染的患者的影响
Alec R Raley1, Matthew L Brown1, Morgan Frawley1
1University of Alabama at Birmingham, Birmingham, AL, USA.
Hospital pharmacy
|January 15, 2024
概括
范科米辛加重剂量并没有改善梅西林耐药黄金葡萄球菌 (MRSA) 感染的患者的临床结果或安全性. 对于血液动力学稳定的MRSA患者,不建议使用常规的加重剂量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 临床药房 临床药房
背景情况:
- 范科米辛充满剂量经常用于快速达到治疗性血清度.
- 有限的数据存在于万科米辛加重剂量对患者结局的临床影响.
- 修订了机构协议,为怀疑严重MRSA感染的不稳定患者预留充满剂量.
研究的目的:
- 为了评估万科米辛加重剂量的临床疗效和安全性.
- 为了比较之前和之后的结果,改变了限制负载剂量的协议.
主要方法:
- 追溯的,准实验性的研究设计.
- 在 (干预前) 和 (干预后) 协议修订前 (实验室确认) 患有MRSA感染的成年患者的比较.
- 主要结局:全因住院患者死亡率. 二次结局:持续的感染症状,治疗转换,毒性.
主要成果:
- 两组之间的住院患者死亡率没有显著差异 (4.76%对6.78%).
- 在前干预和后干预组之间,持久性感染,需要替代疗法和毒性率相似.
- 接受万科米辛加重剂量并没有影响初级或二级结果.
结论:
- 常规范科米辛加载剂量与患有MRSA感染的血液动力稳定患者的改善临床结果无关.
- 这项研究表明,保留万科米辛加载剂量可能是一个安全有效的策略.
相关概念视频
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Renal Failure: Dose Adjustments
92
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
92
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K


